Quantum Genomics S.A. - PE Ratio
QNNTF
Price:
$0.1
Market Cap:
$5.00M
Quantum Genomics S.A., a biopharmaceutical enterprise headquartered in Paris, France, was established in 2005. The company specializes in advancing therapeutic solutions for cardiovascular ailments. Its drug development efforts are anchored in the brain aminopeptidase A inhibition (BAPAI) platform, primarily targeting hypertension (high blood pressure) and heart failure. Among its pipeline, firibastat is a notable candidate, currently undergoing a crucial Phase III study as a standalone treatment for high blood pressure, and is also progressing through clinical trials for heart failure. Furthermore, Quantum Genomics is developing QGC011 for combination therapy in hypertension, alongside QGC0...[Read more]
Industry
Biotechnology
IPO Date
2021-05-19
Stock Exchange
OTC
Ticker
QNNTF
PE Ratio
[-0.11]
ROE
[880.77%]
Current Ratio
[2.05]
Dividend Yield
[0%]
Enterprise Value
[7.34M]
Dividend History
The PE Ratio as of June 2026 (TTM) for Quantum Genomics S.A. (QNNTF) is -0.11
According to Quantum Genomics S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -0.11. This represents a change of -86.94% compared to the average of -0.87 of the last 4 quarters.
Quantum Genomics S.A. (QNNTF) Historical PE Ratio (quarterly & annually)
How has QNNTF PE Ratio performed in the past?
The mean historical PE Ratio of Quantum Genomics S.A. over the last ten years is -5.93. The current -0.11 PE Ratio has changed 91.67% with respect to the historical average. Over the past ten years (40 quarters), QNNTF's PE Ratio was at its highest in in the December 2009 quarter at 0. The PE Ratio was at its lowest in in the December 2011 quarter at -69.30.
Average
-5.93
Median
-6.41
Minimum
-15.57
Maximum
-0.16
Quantum Genomics S.A. (QNNTF) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Quantum Genomics S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 613.15%
Maximum Annual PE Ratio = -0.16
Minimum Annual Increase = -97.55%
Minimum Annual PE Ratio = -15.57
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -0.57 | -51.50% |
| 2023 | -1.17 | 613.15% |
| 2022 | -0.16 | -97.55% |
| 2021 | -6.66 | 7.99% |
| 2020 | -6.16 | -7.91% |
| 2019 | -6.69 | -4.37% |
| 2018 | -7.00 | 95.98% |
| 2017 | -3.57 | -69.55% |
| 2016 | -11.73 | -24.67% |
| 2015 | -15.57 | 29.72% |
Quantum Genomics S.A. (QNNTF) Average PE Ratio
How has QNNTF PE Ratio performed in the past?
The current PE Ratio of Quantum Genomics S.A. (QNNTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.63
5-year avg
-2.94
10-year avg
-5.93
Quantum Genomics S.A. (QNNTF) PE Ratio vs. Peers
How is QNNTF’s PE Ratio compared to its peers?
Quantum Genomics S.A.’s PE Ratio is greater than Chimeric Therapeutics Limited (-0.12), less than Theralink Technologies, Inc. (-0.00), greater than Curative Biotechnology, Inc. (-2.74), less than LianBio (2.47), greater than BetterLife Pharma Inc. (-6.44), greater than PharmaTher Holdings Ltd. (-5.37), greater than Tristar Wellness Solutions Inc. (-7.50), less than ProText Mobility, Inc. (55.00), greater than NanoSphere Health Sciences Inc. (-1.76), greater than Glow Lifetech Corp. (-26.47),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.12 | $4.10M | |
| -0.00 | $615.15K | |
| -2.74 | $8.96M | |
| 2.47 | $12.11M | |
| -6.44 | $7.77M | |
| -5.37 | $4.00M | |
| -7.50 | $42.00K | |
| 55.00 | $10.71M | |
| -1.76 | $98.64K | |
| -26.47 | $6.13M |
Build a custom stock screener for Quantum Genomics S.A. (QNNTF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Quantum Genomics S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Quantum Genomics S.A. (QNNTF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Quantum Genomics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Quantum Genomics S.A.'s PE Ratio?
How is the PE Ratio calculated for Quantum Genomics S.A. (QNNTF)?
What is the highest PE Ratio for Quantum Genomics S.A. (QNNTF)?
What is the 3-year average PE Ratio for Quantum Genomics S.A. (QNNTF)?
What is the 5-year average PE Ratio for Quantum Genomics S.A. (QNNTF)?
How does the current PE Ratio for Quantum Genomics S.A. (QNNTF) compare to its historical average?